You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 17, 2025

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
Published on: March 31, 2023
Yingying Ning1, Eman A Akam-Baxter1,2, Peter Caravan1
1Athinoula A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, United States.
Researchers developed novel molecular probes to detect and monitor fibrosis, a key factor in many diseases. These probes target lysine aldehyde (LysAld), a biomarker elevated during fibrogenesis, enabling noninvasive imaging for diagnosis and treatment tracking.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: